Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

ONCOLife

Novel Biomarker-Driven Treatments with ADCs in NSC Lung Cancer Management

ONCOLife

Role of CGP Testing in the Management of Cancer Treatment and Personalized Care

Webinar

Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global

ONCOLife

The SCOPE Trial and SCIB1: Transforming Melanoma Treatment with DNA Plasmid Vaccine

ONCOLife

How Engineered Oncolytic Adenoviruses Could Transform Cancer Treatment

ONCOLife

FDA Approves Itovebi as First-Line Therapy for PIK3CA-Mutated Breast Cancer

ONCOLife

The Next Generation of ADCs and the Potential of ABBV-400 in Lung Cancer Treatment

ONCOLife

The LUMINOSITY Trial And Exploring Novel Biomarker Targets in the Future of ADCs for NSCLC

Featured Articles

FDA Approves First Targeted Therapy for IDH-Mutant Glioma with Companion Diagnostic

21 October 2024

The FDA has approved Thermo Fisher’s Oncomine Dx Target Test, a next-generation sequencing based companion diagnostic, to identify patients eligible for Servier's VORANIGO® (vorasidenib)....

Trending Articles

Lung Cancer Treatment for Never Smokers: The HARMONIC Phase 2 Trial and LP-300

AI-Powered Treatment Success: LP-300 Shows Promise for Non-Smoker Lung Cancer

ONCOLife

12 August 2024

New Developments in Prostate Cancer: The Road to More Personalized Medicine

ONCOLife

26 July 2024

FDA Approves Neffy: First Nasal Spray for Emergency Allergic Reactions

FDA & EMA

10 August 2024

Mixed-Reality System, HipInsight, Receives FDA Approval for Hip Surgery

FDA & EMA

13 August 2024

Merck Ends KeyVibe-008 Trial Over Safety Concerns: A Setback in Lung Cancer

Elevating Safety and Efficacy in Brain Tumor Treatment with the NB3 Laser Probe

ONCOLife

23 July 2024

Healthy Planet: How The Pharmaceutical Industry Can Reduce Its Emissions

Opinion

9 August 2024

The Role of Pharmacists in the Fight Against Liver Disease / Interview with Dr. Duggan

Pharma

9 August 2024

Iptacopan, the First CI, Wins FDA Accelerated Approval for IgA Nephropathy

FDA & EMA

8 August 2024

FDA Approves Vorasidenib as First Targeted Therapy for G2 IDH-Mutant Glioma

Novel CAR T Cell Therapy Targets Brain Cancer's Hidden Pathways, Doubling Survival

ONCOLife

6 August 2024

The Impact of Comprehensive Genomic Profiling on Personalized Cancer Care

ONCOLife

17 July 2024

Novel Immunotherapy IMNN-001 Shows Extended Survival Rates for Ovarian Cancer

ONCOLife

3 August 2024

FDA Approves Expanded Use of Dostarlimab for Treatment of Endometrial Cancers

FDA & EMA

2 August 2024